Zobrazeno 1 - 10
of 16
pro vyhledávání: '"R J, Kania"'
Publikováno v:
Journal of Viral Hepatitis. 4:101-106
An open label trial of GM-CSF plus high-dose interferon (IFN) alpha 2b was performed in eight patients with chronic hepatitis B infection and 16 patients with chronic hepatitis C, who either failed to clear virus with 6 months of daily high-dose IFN
Publikováno v:
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. :M330-M333
BACKGROUND Hepatitis C virus (HCV) is a health problem that is common in adults. Because screening of blood and blood products for HCV has only been possible recently, older adults are more likely than younger adults to have HCV. Despite the higher p
Publikováno v:
2011 Abstracts IEEE International Conference on Plasma Science.
Summary form only given. The object of this work was to continue the study of sterilization of antibiotic resistant bacteria using the atmospheric pressure cold plasma apparatus used so successfully in St. Jude Research Hospital in Memphis, TN. The n
Publikováno v:
Hepato-gastroenterology. 46(28)
Treatment of chronic hepatitis B virus (HBV) infection in an individual with periarteritis nodosum is described. A combination of famciclovir, granulocyte macrophage colony stimulating factor (GM-CSF) and interferon alpha 2b was utilized. The periart
Publikováno v:
Hepato-gastroenterology. 45(20)
The problems associated with the recognition and management of chronic hepatitis C in a population of individuals with confounding psychiatric disease are identified. The experience of treating such patients and the psychotropic medication required d
Autor:
D H, Van Thiel, L, Friedlander, R J, Kania, P J, Molloy, T, Hassanein, E, Wahlstrom, H, Faruki
Publikováno v:
Hepato-gastroenterology. 44(15)
The purpose of this study was to evaluate the effectiveness and safety of lamivudine treatment in patients with advanced and end-stage liver disease caused by hepatitis B. Nine cases of advanced or end-stage liver disease due to hepatitis B infection
Publikováno v:
Digestive diseases and sciences. 41(8)
Chronic viral hepatitis C is a problem of immense proportions. The only therapy that currently exists and is FDA approved is interferon (IFN). Much controversy exists regarding the dose and duration as well as the effectiveness of IFN therapy. This s
Successful empiric treatment of HSV hepatitis in pregnancy. Case report and review of the literature
Publikováno v:
Digestive diseases and sciences. 41(6)
Autor:
D H, Van Thiel, L, Friedlander, P J, Molloy, R J, Kania, S, Fagiuoli, H I, Wright, A, Gasbarrini, P, Caraceni
Interferon α (IFN) is the only agent currently approved by the FDA for the treatment of chronic viral hepatitis due to hepatitis C (HCV). Unfortunately, less than half the patients with HCV treated with IFN respond. Worse yet, half or more of those
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::33fa6d5d9191a64f557aef3db398e9d3
http://hdl.handle.net/10281/353283
http://hdl.handle.net/10281/353283
Objective: To determine whether individuals with concurrent active psychiatric disease and chronic hepatitis C virus (HCV) can be treated safely and effectively with interferon-alpha. Design: Prospective, open label study. Setting: Tertiary referral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::58b26c7ed63c259c83c413b075add457
http://hdl.handle.net/10281/353100
http://hdl.handle.net/10281/353100